Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
Recruiting
N/A
Interventional Study
Lung Cancer
Surgery
Blood Pressure Management
Dexamethasone
Overall Survival
Postoperative Complications
At a Glance
- Age
- 50 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 1,988 (estimated)
- Sponsor
- Peking University First Hospital · Other
Who this trial is looking for
This trial is looking for patients aged 50 to 90 who are scheduled for surgery for lung cancer. Participation involves management of blood pressure during surgery and the use of dexamethasone to see how these affect recovery.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 50 and 90 years old.
- I have been diagnosed with resectable non-small cell lung cancer.
- I am scheduled for radical surgery lasting more than 2 hours.
- I agree to participate in this study and sign the consent form.
You may not be able to join if
- I have non-resectable lung cancer.
- I have recurrent or metastatic lung cancer.
- I have a history of cancer in other organs.
- I have frequently taken glucocorticoids or immunosuppressants.
- I have uncontrolled high blood pressure.
- I have had heart problems like atrial fibrillation in the last 3 months.
- I have severe liver dysfunction or kidney failure.
- My doctor thinks I should not participate.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Surgery is the front-line therapy for non-small cell lung cancer (NSCLC) but postoperative complications remains high and patients' long-term outcome is still challenging. In addition to surgery, anesthetic management particularly intraoperative blood pressure management and use of dexamethasone may affect patients' early and long-term outcomes after surgery for NSCLC. This study aims to investiga…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged \>50 years but \<90 years.
* Diagnosed as resectable primary non-small cell lung cancer (stage IA-IIIA) and scheduled for radical surgery with an expected duration of \>2 hours.
* Agree to participate in this study and sign the informed consent.
Exclusion Criteria:
* Cl…
Contacts